Key result
Four-pillar guideline-directed medical therapy reaches only ~47% of heart failure outpatients.
Why the study?
Real-world uptake of all four foundational GDMT pillars in heart failure remains incomplete, and contemporary data from the Gulf region are limited.
Observational (n=250)
No
In a contemporary tertiary Bahraini heart failure cohort, overall foundational therapy uptake was high, but fewer than half of patients received all four GDMT pillars (with SGLT2 inhibitors representing the largest implementation gap at 59.7%), and two-thirds of tested patients had iron deficiency.
Answers are grounded in this paper and cite their sources.
Incomplete four-pillar GDMT receipt in HF outpatients supports targeted implementation research; leaves open associations with recent hospitalizations.
Objectives: Guideline-directed medical therapy (GDMT) reduces morbidity and mortality in heart failure with reduced ejection fraction, yet real-world uptake of all four foundational pillars remains incomplete, and contemporary Gulf data are limited. We characterized heart failure phenotypes, etiologies, GDMT uptake, iron-status assessment, and factors associated with recent hospitalization in a tertiary cohort in Bahrain. Methods: We conducted a retrospective observational study of 250 consecutive adult heart failure outpatients managed at a national tertiary cardiac center between January and June 2024. Patients were stratified by left ventricular ejection fraction (LVEF) into reduced (≤40%), mildly reduced (41–49%), and preserved (≥50%) phenotypes. We assessed GDMT across four pillars: renin–angiotensin system (RAS) inhibition, beta-blockade, mineralocorticoid receptor antagonism, and sodium–glucose cotransporter 2 (SGLT2) inhibition. Multivariable logistic regression identified factors associated with at least one heart failure hospitalization during the previous 12 months. Guideline-defined iron deficiency was assessed in patients with complete iron studies. Results: Mean age was 60.7 years, 68.4% were male, and reduced ejection fraction predominated (84.4%). RAS inhibitor and beta-blocker use were high (92.9% and 94.8%), whereas mineralocorticoid receptor antagonist (MRA) (73.5%) and SGLT2 inhibitor (59.7%) use were lower; 78.7% received at least three pillars, and 47.4% received all four. Iron deficiency was present in 83 of 124 assessable patients (66.9%). Prior hospitalization had occurred in 82 patients (32.8%). In multivariable analysis, hypertension and New York Heart Association (NYHA) class II–IV were associated with higher odds of prior hospitalization, whereas higher hemoglobin was associated with lower odds. Conclusions: In this contemporary Bahraini cohort, foundational therapy uptake was high, though SGLT2 inhibitors represented the largest four-pillar gap, and fewer than half received all four pillars. Guideline-defined iron deficiency was highly prevalent among assessable patients. Hypertension, greater symptomatic limitation, and lower hemoglobin were independently associated with prior hospitalization.
No takes yet. Share an insight, caveat, or question.
Hamad et al. (2026) conducted an observational in Heart failure (n=250). Four-pillar guideline-directed medical therapy (RAS inhibition, beta-blockade, MRA, SGLT2 inhibition) was evaluated on Receipt of all four pillars of guideline-directed medical therapy. Four-pillar guideline-directed medical therapy was received by 47.4% of heart failure outpatients, while 32.8% had a prior heart failure hospitalization in the preceding 12 months.
Synapse has enriched 10 related papers. Consider them for comparative context: